Hawkins posts record Q2 sales of $247.0 million and diluted EPS of $1.16
Hawkins reported fiscal 2025 second-quarter results for the quarter ended September 29, 2024, with sales up 4% to $247.0 million and net income of $24.1 million. Growth came from the Water Treatment segment, which rose 23% on acquisitions, while Industrial and Health and Nutrition sales declined. The company described the quarter as a record for revenue, gross profit, operating income, net income and diluted EPS.
Key points
- Diluted EPS was $1.16, up $0.06, or 5%, from $1.10 a year earlier.
- Water Treatment sales rose $23.6 million, or 23%, to $124.5 million; Industrial sales fell 9% to $89.9 million.
- Operating income was $33.7 million; adjusted EBITDA, a non-GAAP measure, was $46.3 million, up 12%.
- The company paid down $30 million on its line of credit in the quarter and reported a leverage ratio of 0.65x.
The filing
Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 30, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.